A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease

Although [(18)F]fluoro-L-dopa [FDOPA] positron emission tomography (PET) has been used as a surrogate outcome measure in Parkinson's disease therapeutic trials, this biomarker has not been proven to reflect clinical status longitudinally. We completed a retrospective analysis of relationships b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gallagher, Catherine L., Johnson, Sterling C., Bendlin, Barbara B., Chung, Moo K., Holden, James E., Oakes, Terrence R., Brooks, Benjamin R., Konopacki, Richard A., Dogan, Selami, Abbs, James H., Xu, Guofan, Nickles, Robert J., Pyzalski, Robert W., DeJesus, Onofre T., Brown, W. Douglas
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3150388/
https://ncbi.nlm.nih.gov/pubmed/21556744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11682-011-9124-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi